Medicine and Dentistry
Systematic Review
100%
Bariatric Surgery
99%
Meta-Analysis
98%
Maturity Onset Diabetes of the Young
97%
Polycystic Ovary Syndrome
87%
COVID-19
82%
Cardiovascular System
59%
Global Disease Burden
45%
Disability Adjusted Life Years
44%
Neuroendocrine Tumor
42%
Neoplasm
42%
Prevalence
41%
Parathyroid Carcinoma
41%
Plerixafor
41%
Hematopoietic Cell
41%
Hypoglycemia
41%
Hyponatremia
41%
COVID-19 Therapy
41%
Diseases
40%
Insulin Resistance
40%
Low Drug Dose
38%
High Dose Chemotherapy
36%
Body Mass Index
36%
Cross Sectional Study
30%
Brown Adipose Tissue
30%
Germinoma
30%
Acute Coronary Syndrome
29%
Prolactin
29%
Drug Megadose
28%
Randomized Controlled Trial
27%
Polycystic Ovarian Syndrome
27%
Medicine
27%
Empagliflozin
27%
Ectopic Hormone Production
27%
Metabolic Disorder
27%
Atherosclerosis
27%
Knockout Mouse
27%
Meta-Regression
27%
Tolvaptan
27%
Magnetic Resonance Imaging
26%
Cancer
25%
Endocrine Disease
25%
Diabetes Mellitus
24%
Prolactinoma
24%
Artificial Respiration
24%
Cardiovascular Disease
23%
Pancreas Islet Cell Tumor
22%
Hydrocortisone
22%
Hyperlipidemia
22%
Lung
21%
Pharmacology, Toxicology and Pharmaceutical Science
Atherosclerosis
44%
Ovary Polycystic Disease
41%
Parathyroid Carcinoma
41%
Plerixafor
41%
Glucagon Like Peptide 1 Receptor Agonist
41%
Tirzepatide
41%
Diseases
40%
High Dose Chemotherapy
39%
Non Insulin Dependent Diabetes Mellitus
38%
Nonalcoholic Fatty Liver
33%
Inflammation
33%
Syndrome
31%
Germ Cell Tumor
30%
Empagliflozin
27%
Tolvaptan
27%
Hyponatremia
27%
Cross-Sectional Study
27%
Knockout Mouse
27%
Baricitinib
27%
Neoplasm
26%
Prevalence
26%
Hyperlipidemia
22%
Chemotherapy
19%
All Cause Mortality
19%
Heart Infarction
18%
Global Disease Burden
18%
Gelatinase A
18%
Tissue Inhibitor of Metalloproteinase
17%
Granulocyte Colony Stimulating Factor
16%
Biological Marker
16%
Mortality Rate
15%
Neuroendocrine Tumor
15%
Semaglutide
15%
Adipocytokine
14%
Insulin Sensitizing Agent
14%
Placebo
14%
Mitotane
13%
Chemerin
13%
Orexin Receptor
13%
Paclitaxel
13%
Sleep Disordered Breathing
13%
Adrenal Cortex Carcinoma
13%
Pharmacokinetic
13%
Gastrointestinal Hormone
13%
Incretin
13%
Ravulizumab
13%
Metabolic Disorder
13%
Prospective Cohort Study
13%
Ifosfamide
13%
Endocrine Tumor
13%
Nursing and Health Professions
Systematic Review
59%
Meta Analysis
53%
Bariatric Surgery
29%
Diseases
29%
Neuroendocrine Tumor
29%
Cross-Sectional Study
27%
Prevalence
25%
Non Insulin Dependent Diabetes Mellitus
22%
Vitamin D
17%
Pancreas Islet Cell Tumor
16%
Quality of Life
15%
Umbrella Review
13%
Morbid Obesity
13%
Sleep Disordered Breathing
13%
Sleep Quality
13%
Anthropometry
13%
Pheochromocytoma
13%
Paraganglioma
13%
Parathyroid Carcinoma
13%
Pregnancy Diabetes Mellitus
13%
Prospective Cohort Study
13%
Supplementation
13%
Self Evaluation
13%
Behavior Modification
13%
Baricitinib
13%
Fatty Liver
13%
Colecalciferol
13%
Calcitonin
13%
Ovary Polycystic Disease
13%
Vitamin D Deficiency
13%
Adrenal Cortex Carcinoma
13%
Transsphenoidal Surgery
13%
Mitotane
13%
Urine Incontinence
13%
Glucose Blood Level
13%
Empagliflozin
13%
Pharmacokinetic Parameters
13%
Hyponatremia
13%
Metabolic Disorder
13%
Fumaric Acid Dimethyl Ester
13%
Fibrosis
11%
Mortality Rate
11%
Enuresis
11%
Thyroid Medullary Carcinoma
9%
Body Mass
9%
Nonalcoholic Fatty Liver
9%
Hyperlipidemia
9%
Disability-Adjusted Life Year
9%
Artificial Respiration
8%
World Health Organization
8%